Awaiting the outcome of the Patient Capital Review with an eagerness that borders on, well, impatience, Ian Battersby wonders how financial advisers will be expected to embrace whatever new rules emerge
The results of the Patient Capital Review are eagerly anticipated by tax-advantaged product providers, advisers and investors alike but, at the present time, there is very little clarity about what might...
'FCA indicated it could penalise the firm'
The first rule of customer service
Sold property business
Warning of consumer credit bubble
12 financial planners on the panel